Bragina, O., von Witting, E., Garousi, J., Zelchan, R., Sandström, M., Orlova, A., Medvedeva, A., Doroshenko, A., Vorobyeva, A., Lindbo, S., Borin, J., Tarabanovskaya, N., Sörensen, J., Hober, S., Chernov, V., & Tolmachev, V. Phase I Study of 99mTc-ADAPT6, a Scaffold Protein-Based Probe for Visualization of HER2 Expression in Breast Cancer //Journal of nuclear medicine. – 2021. – Vol. 62. – No. 4. – P. 493–499. DOI:10.2967/jnumed.120.248799 https://jnm.snmjournals.org/content/62/4/493
Bragina, O., Chernov, V., Schulga, A., Konovalova, E., Garbukov, E., Vorobyeva, A., Orlova, A., Tashireva, L., Sorensen, J., Zelchan, R., Medvedeva, A., Deyev, S., & Tolmachev, V. Phase I trial of 99mTc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer //Journal of nuclear medicine: official publication, Society of Nuclear Medicine.– 2021. – jnumed.121.262542. Advance online publication. DOI:10.2967/jnumed.121.262542 https://jnm.snmjournals.org/content/early/2021/08/12/jnumed.121.262542
Tano, H., Oroujeni, M., Vorobyeva, A., Westerlund, K., Liu, Y., Xu, T., Vasconcelos, D., Orlova, A., Karlström, A.E., Tolmachev, V. Comparative Evaluation of Novel 177Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting //Cancers. – 2021. – Vol. 13. – No. 3. – P. 500. DOI: 10.3390/cancers13030500 https://www.mdpi.com/2072-6694/13/3/500
Garousi, J., von Witting, E., Borin, J., Vorobyeva, A., Altai, M., Vorontsova, O., Konijnenberg, M.W., Oroujeni, M., Orlova, A., Tolmachev, V. Hober, S. Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle //Biomaterials. – 2021. – Vol. 266. – P. 120381 DOI:10.1016/j.biomaterials.2020.120381 https://www.sciencedirect.com/science/article/pii/S014296122030627X
Oroujeni, M., Rinne, S.S., Vorobyeva, A., Loftenius, A., Feldwisch, J., Jonasson, P., Chernov, V., Orlova, A., Frejd, F.Y., Tolmachev, V. Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake //International Journal of Molecular Sciences. – 2021. – Vol. 22. – No. 2770. DOI:10.3390/ijms22052770 https://www.mdpi.com/1422-0067/22/5/2770
Abouzayed, A., Rinne, S. S., Sabahnoo, H., Sörensen, J., Chernov, V., Tolmachev, V., Orlova, A. Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer //Pharmaceutics. – 2021. – Vol. 13. – No. 2. – P. 182. DOI: 10.3390/pharmaceutics13020182 https://www.mdpi.com/1999-4923/13/2/182
Oroujeni, M., Xu, T., Gagnon, K., Rinne, S.S., Weis, J., Garousi, J., Andersson, K.G., Löfblom, J., Orlova, A. and Tolmachev, V. Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody Molecule //Pharmaceutics. – 2021. – Vol. 13. – No. 292. DOI: 10.3390/pharmaceutics13020292 https://www.mdpi.com/1999-4923/13/2/292
Rinne, S.S.; Leitao, C.D.; Abouzayed, A.; Vorobyeva, A.; Tolmachev, V.; Ståhl, S.; Löfblom, J.; Orlova, A. HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers. Cancers. – 2021. – Vol. 13.– P. 4791. DOI:10.3390/cancers13194791 https://www.mdpi.com/2072-6694/13/19/4791
Xu, T., Vorobyeva, A., Schulga, A., Konovalova, E., Vorontsova, O., Ding, H., Gräslund, T., Tashireva, L. A., Orlova, A., Tolmachev, V., & Deyev, S. M. Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model //Cancers.– 2021. – Vol. 13. – No. 16. – P. 3939. DOI:10.3390/cancers13163939 https://www.mdpi.com/2072-6694/13/16/3939
Deyev, S. M., Xu, T., Liu, Y., Schulga, A., Konovalova, E., Garousi, J., Rinne, S. S., Larkina, M., Ding, H., Gräslund, T., Orlova, A., Tolmachev, V., & Vorobyeva, A. Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1 //Cancers.– 2021. – Vol. 13. – No. 14. – P. 3589. DOI:10.3390/cancers13143589 https://www.mdpi.com/2072-6694/13/14/3589
Liu, Y., Vorobyeva, A., Xu, T., Orlova, A., Loftenius, A., Bengtsson, T., Jonasson, P., Tolmachev, V., & Frejd, F. Y. Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain //Pharmaceutics.– 2021. – Vol. 13. – No. 6. – P. 839. DOI:10.3390/pharmaceutics1306083 https://pubmed.ncbi.nlm.nih.gov/34200197
Rinne, S. S., Orlova, A., & Tolmachev, V. PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology //International journal of molecular sciences. – 2021. – Vol. 22. – No. 7. – P. 3663. DOI: 10.3390/ijms22073663 https://www.mdpi.com/1422-0067/22/7/3663
Rinne, S.S., Abouzayed, A., Gagnon, K., Tolmachev, V., Orlova, A. 66 Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [66 Ga] Ga-NOTA-PEG 2-RM26 //Scientific reports. – 2021. – Vol. 11. – No. 1. – P. 1-12. DOI: 10.1038/s41598-021-82995-7 https://pubmed.ncbi.nlm.nih.gov/33574368
Oroujeni, M., Xu, T., Gagnon, K., Rinne, S.S., Weis, J., Garousi, J., Andersson, K.G., Löfblom, J., Orlova, A. and Tolmachev, V. Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody Molecule //Pharmaceutics. – 2021. – Vol. 13. – No. 292. DOI: 10.3390/pharmaceutics13020292 https://www.mdpi.com/1999-4923/13/2/292
Abouzayed, A., Rinne, S. S., Sabahnoo, H., Sörensen, J., Chernov, V., Tolmachev, V., Orlova, A. Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer //Pharmaceutics. – 2021. – Vol. 13. – No. 2. – P. 182. DOI: 10.3390/pharmaceutics13020182 https://www.mdpi.com/1999-4923/13/2/182
Oroujeni, M., Rinne, S.S., Vorobyeva, A., Loftenius, A., Feldwisch, J., Jonasson, P., Chernov, V., Orlova, A., Frejd, F.Y., Tolmachev, V. Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake //International Journal of Molecular Sciences. – 2021. – Vol. 22. – No. 2770. DOI:10.3390/ijms22052770 https://www.mdpi.com/1422-0067/22/5/277
Garousi, J., von Witting, E., Borin, J., Vorobyeva, A., Altai, M., Vorontsova, O., Konijnenberg, M.W., Oroujeni, M., Orlova, A., Tolmachev, V. Hober, S. Radionuclide therapy using ABD-fused ADAPT scaffold protein: Proof of Principle //Biomaterials. – 2021. – Vol. 266. – P. 120381 DOI:10.1016/j.biomaterials.2020.120381 https://www.sciencedirect.com/science/article/pii/S014296122030627X
Xu, T., Ding, H., Vorobyeva, A., Oroujeni, M., Orlova, A., Tolmachev, V., Graslung, T. Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model //Cancers. – 2021. – Vol. 13. – No. 85. – P. 1-21. DOI: 10.3390/cansers13010085 https://www.mdpi.com/2072-6694/13/1/85
Tano, H., Oroujeni, M., Vorobyeva, A., Westerlund, K., Liu, Y., Xu, T., Vasconcelos, D., Orlova, A., Karlström, A.E., Tolmachev, V. Comparative Evaluation of Novel 177Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting //Cancers. – 2021. – Vol. 13. – No. 3. – P. 500. DOI: 10.3390/cancers13030500 https://www.mdpi.com/2072-6694/13/3/500
Tolmachev, V., Orlova, A., & Sörensen, J. The emerging role of radionuclide molecular imaging of HER2 expression in breast cancer //Seminars in Cancer Biology. – Academic Press, 2021. DOI: 10.1016/j.semcancer.2020.10.005 https://www.sciencedirect.com/science/article/pii/S1044579X20302108
Ding, H., Xu, T., Zhang, J., Tolmachev, V., Oroujeni, M., Orlova, A., Gräslund, T., Vorobyeva, A. Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution //Pharmaceutics. – 2021. – Vol. 13. – No. 430. DOI: 10.3390/pharmaceutics13030430. https://www.mdpi.com/search?q=Affibody-Derived+Drug+&journal=pharmaceutics
Zelepukin, I.V., Popov, A.A., Shipunova, V.O., Tikhonowski, G.V., Mirkasymov, A.B., Popova-Kuznetsova, E.A., Klimentov, S.M., Kabashin, A.V., Deyev, S.M. Laser-synthesized TiN nanoparticles for biomedical applications: evaluation of safety, biodistribution and pharmacokinetics //Materials Science and Engineering: C. – 2021. – Vol. 120. – P. 111717. DOI:10.1016/j.msec.2020.111717 https://www.sciencedirect.com/science/article/pii/S0928493120336365
Dudnikova Y.A., Chernov V.I., Muravleva A.V., Kravchuk T.L., Zelchan R.V., Medvedeva A.A., Bragina O.D., Simolina Y.L., Popova N.O., Vysockaja V.V., Lukina N.M., Shatalova V.A., Shpileva O.V., Goldberg A.V., Goldberg V.Y. Metabolic single-photon emission computed tomography with the new radiopharmceutical 99Tc-1-thio-D-glucose in the diagnosis and monitoring of the primary breast lymphoma (case report) //Siberian journal of oncology. – 2020. – Vol. 19. – No.5. – P. 145-153. DOI: 10.21294/1814-4861-2020-19-5-145-153 https://www.siboncoj.ru/jour/article/view/1589
Dudnikova Y.A., Chernov V.I., Muravleva A.V., Kravchuk T.L., Zelchan R.V., Medvedeva A.A., Bragina O.D., Simolina Y.L., Popova N.O., Vysockaja V.V., Lukina N.M., Shatalova V.A., Shpileva O.V., Goldberg A.V., Goldberg V.Y. Metabolic single-photon emission computed tomography with the new radiopharmceutical 99Tc-1-thio-D-glucose in the diagnosis and monitoring of the primary breast lymphoma (case report) //Siberian journal of oncology. – 2020. – Vol. 19. – No.5. – P. 145-153.Vorobyeva, A., DOI: 10.21294/1814-4861-2020-19-5-145-153 https://www.siboncoj.ru/jour/article/view/1589?locale=en_US
Vorobyeva, A., Bezverkhniaia, E., Konovalova, E., Schulga, A., Garousi, J., Vorontsova, O., Abouzayed, A., Orlova, A., Deyev, S., Tolmachev, V. Radionuclide molecular imaging of EpCAM expression in triple-negative breast cancer using the scaffold protein DARPin Ec1 //Molecules. – 2020. – Vol. 25. – No. 20. – P. 4719. DOI: 10.3390/molecules25204719 https://www.mdpi.com/1420-3049/25/20/4719
Shramova, E. I., Kotlyar, A. B., Lebedenko, E. N., Deyev, S. M., Proshkina, G. M. Near-Infrared Activated Cyanine Dyes As Agents for Photothermal Therapy and Diagnosis of Tumors.//Acta Nature. – 2020. – Vol. 12. – No. 3(46). – P. 102-113. DOI: 10.32607/actanaturae.11028 http://actanaturae.ru/2075-8251/article/view/11028
Lundmark, F., Abouzayed, A., Mitran, B., Rinne, S.S., Varasteh, Z., Larhed, M., Tolmachev, V., Rosenström, U., Orlova, A. Heterodimeric radiotracer targeting PSMA and GRPR for imaging of prostate cancer—optimization of the affinity towards PSMA by linker modification in murine model //Pharmaceutics. – 2020. – Vol. 12. – No. 7. – P. 614. DOI: 10.3390/pharmaceutics12070614 https://www.mdpi.com/1999-4923/12/7/614
Shramova, E., Proshkina, G., Shipunova, V., Ryabova, A., Kamyshinsky, R., Konevega, A., Schulga, A., Konovalova, E., Telegin, G., Deyev, S. Dual targeting of cancer cells with darpin-based toxins for overcoming tumor escape //Cancers. – 2020. – Vol. 12. – No. 10. – P. 3014. DOI:10.3390/cancers12103014 https://www.mdpi.com/2072-6694/12/10/3014
Garousi, J., Vorobyeva, A. and Altai, M., 2020. Influence of Several Compounds and Drugs on the Renal Uptake of Radiolabeled Affibody Molecules //Molecules. – 2020. – Vol. 25. – No. 11. – P. 2673. DOI: 10.3390/molecules25112673 https://www.mdpi.com/1420-3049/25/11/2673
Vorobyeva, A., Oroujeni, M., Lindbo, S., Hober, S., Xu, T., Liu, Y., Rinne, S.S. and Garousi, J., 2020. Investigation of a pharmacological approach for reduction of renal uptake of radiolabeled adapt scaffold protein //Molecules. – 2020. – Vol. 25. – No. 19. – P. 4448. DOI:10.3390/molecules25194448 https://www.mdpi.com/1420-3049/25/19/4448
Trofimova, E.S., Zykova, M.V., Sherstoboev, E.Y., Danilets, M.G., Ligacheva, A.A. and Belousov, M.V. Effects of Humic Acids, Isolated from High-Moor Pine-Peat Moss-Cotton Grass Peat on the Production of Cytokines by Mouse and Human Immunocompetent Cells and on Humoral Immune Response // Bulletin of experimental biology and medicine. – 2020. – Vol. 168. – No. 5. – P. 651-653. DOI:10.1007/s10517-020-047722 . https://search.proquest.com/openview/2692d43b9f3d023a5faf9ed38ab29aea/1?cbl=47742&pq-origsite=gscholar
Guler, R., Svedmark, S. F., Abouzayed, A., Orlova, A., & Lofblom, J. Increasing thermal stability and improving biodistribution of VEGFR2-binding affibody molecules by a combination of in silico and directed evolution approaches //Scientific reports. – 2020. – Vol. 10. – No. 1. – P. 1-14. DOI: 10.1038/s41598-020-74560-5 https://www.nature.com/articles/s41598-020-74560-5
Baun, C., Mitran, B., Rinne, S. S., Dam, J. H., Olsen, B. B., Tolmachev, V., Orlova, A. Thisgaard, H. Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer //Molecules. 2020. – Vol. 25. – No. 24. – P. 5993. DOI: 10.3390/molecules25245993 https://www.mdpi.com/1420-3049/25/24/5993
Myrhammar, A., Vorobyeva, A., Westerlund, K., Yoneoka, S., Orlova, A., Tsukahara, T., & Altai, M. Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting //Scientific Reports. – 2020. – Vol. 10. – No. 1. – P. 1-12. DOI: 10.1038/s41598-020-77523-y https://www.nature.com/articles/s41598-020-77523-y
Abouzayed, A., Tano, H., Nagy, A., Rinne, S.S., Wadeea, F., Kumar, S., Westerlund, K., Tolmachev, V., Karlstrom, A.E., Orlova, A. Preclinical evaluation of the grpr-targeting antagonist rm26 conjugated to the albumin-binding domain for grpr-targeting therapy of cancer // Pharmaceutics. – 2020. – Vol. 12. – No. 10. – P. 977. DOI: 10.3390/pharmaceutics12100977 https://www.mdpi.com/1999-4923/12/10/977
Leitao, C.D., Rinne, S.S., Altai, M., Vorontsova, O., Dunas, F., Jonasson, P., Tolmachev, V., Lofblom, J., Stahl, S., Orlova, A. Evaluating the therapeutic efficacy of mono-and bivalent affibody-based fusion proteins targeting HER3 in a pancreatic cancer xenograft model //Pharmaceutics. – 2020. – Vol. 12. – No. 6. – P. 551. DOI: 10.3390/pharmaceutics12060551 https://www.mdpi.com/1999-4923/12/6/551
Ding, H., Altai, M., Yin, W., Lindbo, S., Liu, H., Garousi, J., Xu, T., Orlova, A., Tolmachev, V., Hober, S., Graslund, T. HER2-specific pseudomonas exotoxin a pe25 based fusions: Influence of targeting domain on target binding, toxicity, and in vivo biodistribution //Pharmaceutics. – 2020. – Vol. 12. – No. 4. – P. 391. DOI: 10.3390/pharmaceutics12040391 https://www.mdpi.com/1999-4923/12/4/391/htm
Tolmachev, V., Orlova, A. Affibody molecules as targeting vectors for PET imaging //Cancers. – 2020. – Vol. 12. – No. 3. – P. 651. DOI: 10.3390/cancers12030651 https://www.mdpi.com/2072-6694/12/3/651
Rinne, S.S., Leitao, C.D., Saleh-Nihad, Z., Mitran, B., Tolmachev, V., Stahl, S., Lofblom, J., Orlova, A. Benefit of later-time-point PET imaging of her3 expression using optimized radiocobalt-labeled affibody molecules //International journal of molecular sciences. – 2020. – Vol. 21. – No. 6. – P. 1972. DOI: 10.3390/ijms21061972 https://www.mdpi.com/1422-0067/21/6/1972
Deyev, S.M., Vorobyeva, A., Schulga, A., Abouzayed, A., Gunther, T., Garousi, J., Konovalova, E., Ding, H., Graslund, T., Orlova, A., Tolmachev, V. Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1 //International Journal of Biological Macromolecules. – 2020. – Vol. 145. – P. 216-225. DOI: 10.1016/j.ijbiomac.2019.12.147 https://www.sciencedirect.com/science/article/pii/S0141813019393808
Rinne, S.S., Xu, T., Leitao, C.D., Stahl, S., Lofblom, J., Orlova, A., Tolmachev, V., Vorobyeva, A. Influence of residualizing properties of the radiolabel on radionuclide molecular imaging of HER3 using affibody molecules //International Journal of Molecular Sciences. – 2020. – Vol. 21. – No. 4. – P. 1312. DOI: 10.3390/ijms21041312
Altai, M., Vorobyeva, A., Tolmachev, V., Karlstrom, A.E., Westerlund, K. Preparation of Conjugates for Affibody-Based PNA-Mediated Pretargeting //Peptide Nucleic Acids. – Humana, New York, NY, 2020. – P. 283-304. DOI: 10.1007/978-1-0716-0243-0_18
Bragina, O.D., Vorobyeva, A.G., Tolmachev, V.M., Orlova, A.M., Chernov, V.I., Deyev, S.M., Proshkina, G.N., Shulga, A.A., Larkina, M.S., Medvedeva, A.A., Zelchan, R.V. In vitro and in vivo evaluation of the radiochemical compound based on 99m technetium labelled DARPin9_29 for molecular visualization of malignancies overexpressing Her2/neu [In vitro и in vivo оценка радиохимического соединения на основе меченного 99m-Tc каркасного белка DARPin9_29 для молекулярной визуализации злокачественных образований с гиперэкспрессией Her2/neu] //Medical Radiology and Radiation Safety. – 2020. – Vol. 65. – No. 1. – P. 37-41. DOI: 10.12737/1024-6177-2020-65-1-37-41 https://medradiol.fmbafmbc.ru/journal_medradiol/abstracts/2020/1/37-41_Bragina_et_al.pdf
Vorobyeva, A., Konovalova, E., Xu, T., Schulga, A., Altai, M., Garousi, J., Rinne, S.S., Orlova, A., Tolmachev, V., Deyev, S. Feasibility of imaging epcam expression in ovarian cancer using radiolabeled darpin ec1 //International Journal of Molecular Sciences. – 2020. – Vol. 21. – No. 9. – P. 3310. DOI: 10.3390/ijms21093310 https://www.mdpi.com/1422-0067/21/9/3310/htm
Larkina, M.S., Ozerskaya, A.V., Podrezova, E.V., Belousov, M.V., Tolmachev, V., Zhdankin, V.V., Yusubov, M.S. Efficient Synthesis of w-[18F]Fluoroaliphatic Carboxylic Esters and Acids for Positron Emission Tomography //European Journal of Organic Chemistry. – 2020. – Vol. 2020. – No. 40. – P. 6375-6381. DOI: 10.1002/ejoc.202000934 https://chemistry-europe.onlinelibrary.wiley.com/doi/full/10.1002/ejoc.202000934
Alhuseinalkhudhur, A., Lubberink, M., Lindman, H., Tolmachev, V., Frejd, F.Y., Feldwisch, J., Velikyan, I., Sörensen, J. Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer //EJNMMI research. – 2020. – Vol. 10. – No. 1. – P. 1-10. DOI: 10.1186/s13550-020-0603-9 https://ejnmmires.springeropen.com/articles/10.1186/s13550-020-0603-9
Lar’kina, M.S., Krivoshchekov, S.V., Podrezova, E.V., Bragina, O.D., Chernov, V.I., Nesterov, E.A., Bodenko, V.V., Belousov, M.V., Yusubov, M.S. Validation of an Analytical HPLC Method for a New Diagnostic Octreotide Derivative for Neuroendocrine Tumors //Pharmaceutical Chemistry Journal. – 2019. – Vol. 53. – No. 9. – P. 865-870. DOI: 10.1007/s11094-019-02091-z https://link.springer.com/article/10.1007/s11094-019-02091-z
